Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis

Targeted Oncology ◽

10.1007/s11523-017-0486-5 ◽

2017 ◽

Vol 12 (3) ◽

pp. 309-321 ◽

Author(s):

Xiu-Wei Zhang ◽

Yu-Xiang Ma ◽

Yang Sun ◽

Yu-Bo Cao ◽

Qin Li ◽

...

Keyword(s):

Systematic Review ◽

Pancreatic Cancer ◽

Meta Analysis ◽

Locally Advanced ◽

Cytotoxic Agent ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Nab-paclitaxel plus gemcitabine as first-line treatment for resectable/borderline resectable pancreatic cancer: a systematic review and meta-analysis

Pancreatology ◽

10.1016/j.pan.2019.05.147 ◽

2019 ◽

Vol 19 ◽

pp. S58

Author(s):

Yiyin Zhang ◽

Si Shi ◽

Xianjun Yu

Keyword(s):

Systematic Review ◽

Pancreatic Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Resectable Pancreatic Cancer ◽

Borderline Resectable ◽

Borderline Resectable Pancreatic Cancer ◽

First Line Treatment

Download Full-text

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6603301 ◽

2006 ◽

Vol 95 (5) ◽

pp. 587-592 ◽

Author(s):

G P Stathopoulos ◽

K Syrigos ◽

G Aravantinos ◽

A Polyzos ◽

P Papakotoulas ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Phase Iii ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

Phase Iii Trial ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2019.08.008 ◽

2020 ◽

Vol 11 (4) ◽

pp. 647-651 ◽

Author(s):

Roberto Petrioli ◽

Pamela Torre ◽

Guido Pesola ◽

Giovanni Paganini ◽

Loretta Paolelli ◽

...

Keyword(s):

Older Adults ◽

Pancreatic Cancer ◽

Maintenance Treatment ◽

Locally Advanced ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

769 PUBLICATION Activity and tolerability of combination: capecitabine(c) plus gemcitabine(g) as first-line treatment in patients(pts) with locally advanced/metastatic pancreatic cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81064-x ◽

2005 ◽

Vol 3 (2) ◽

pp. 219-220

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Publication Activity ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Capecitabine (X) plus gemcitabine (G) as first-line treatment in patients (pts) with locally advanced/metastatic pancreatic cancer: an open-label, multicenter phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4141 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4141-4141 ◽

Author(s):

H.-S. Song ◽

Y.-R. Do ◽

H.-M. Chang ◽

K.-H. Lee ◽

Y.-H. Kim ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

FOLFOX-6 Combination as the First-Line Treatment of Locally Advanced and/or Metastatic Pancreatic Cancer

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000235997.18657.a6 ◽

2007 ◽

Vol 30 (1) ◽

pp. 15-20 ◽

Author(s):

Marwan Ghosn ◽

Fadi Farhat ◽

Joseph Kattan ◽

Fariha Younes ◽

Walid Moukadem ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

P-036 Phase II study of gemcitabine and curcumin as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary data

Annals of Oncology ◽

10.1093/annonc/mdv233.36 ◽

2015 ◽

Vol 26 ◽

pp. iv10

Author(s):

C. Soldà ◽

R. Bardini ◽

C. Sperti ◽

G. Da Dalt ◽

M. Gion ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis

Journal of Cancer ◽

10.7150/jca.29898 ◽

2019 ◽

Vol 10 (18) ◽

pp. 4420-4429 ◽

Author(s):

Yiyin Zhang ◽

Jin Xu ◽

Jie Hua ◽

Jiang Liu ◽

Chen Liang ◽

...

Keyword(s):

Systematic Review ◽

Pancreatic Cancer ◽

Meta Analysis ◽

Advanced Pancreatic Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Phase II study of Gemcitabine and Curcumin (Meriva®) as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary results

Annals of Oncology ◽

10.1093/annonc/mdv344.41 ◽

2015 ◽

Vol 26 ◽

pp. vi102 ◽

Author(s):

C. Soldà ◽

R. Bardini ◽

C. Sperti ◽

G. Da Dalt ◽

M. Gion ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

PACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

Annals of Oncology ◽

10.1093/annonc/mdx369.158 ◽

2017 ◽

Vol 28 ◽

pp. v266

Author(s):

I. Chen ◽

J.S. Johansen ◽

T.A. Zimmers ◽

C. Dehlendorff ◽

V. Kirk Parner ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

Single Center ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text